<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Pharma-Etf on Archive 03</title><link>https://archive03.online/en/tags/pharma-etf/</link><description>Recent content in Pharma-Etf on Archive 03</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Sat, 09 Aug 2025 00:00:00 +0000</lastBuildDate><atom:link href="https://archive03.online/en/tags/pharma-etf/index.xml" rel="self" type="application/rss+xml"/><item><title>Pharma ETF $PPH: A Deep Dive into Its Allure and Pitfalls</title><link>https://archive03.online/en/reports/2025-08-09-pharma-etf-pph/</link><pubDate>Sat, 09 Aug 2025 00:00:00 +0000</pubDate><guid>https://archive03.online/en/reports/2025-08-09-pharma-etf-pph/</guid><description>A deep-dive analysis of the VanEck Pharmaceutical ETF ($PPH). Three characters debate the explosive growth potential of its concentrated strategy, focusing on innovators like Eli Lilly, against the clear pitfalls of high valuation and concentration risk.</description></item></channel></rss>